In certain cancers, such as melanoma and colorectal carcinoma, HERV-K (HML-2) envs have been investigated as tumor-associated antigens (TAAs) and tumor-specific antigens (TSAgs) for stimulating immune responses against cancer cells [147,148,149,150]. Here, CLEC10A is linked to cancer.